The Migraine and plant antioxidant: Review article
DOI:
https://doi.org/10.32792/utq/utjsci/v10i1.1061Keywords:
This manuscript interest in biotechnology and the first time research on relationship between migrain and plant antioxidantAbstract
Even though the pathophysiology of migraine has been the subject of many works, the precise molecular mechanism regarding the disturbances that underlie migraine remains unknown. Additionally, it is thought that oxidative stress contributes significantly to migraine development. For many years, the idea that migraine sufferers experience oxidative stress was addressed. The so-called nutraceutics, which include antioxidants, have received a lot of attention in the last few years among the substances which may be utilized to cure migraines. Antioxidants that are supplied with the food prevent the oxidative stress through suppressing the propagation, initiation, and actual oxidative chain reaction. The agents now being utilized to prevent migraines do in fact have certain antioxidative activity. Antioxidants that have been addressed in this research are growing more regularly utilized through the migraine sufferers not just because of low or even lack of side effects, yet as well due to their efficiency (shortening of an episode duration or reduced frequency of migraine episodes).
References
A. Puppe, and V. Limmroth, "GABAergic drugs for the treatment of migraine." CNS Neurol Disord Drug Targets. 6, 247–250, 2007.
B. Colombo, L. Saraceno, and G. Comi, "Riboflavin and migraine the bridge over troubled mitochondria". Neurol Sci. 35, 141–144, 2014.
E.C. Gross, R. J. Klement, J. Schenen, D.P. D’Agostino, and D. Fischer, "Potential protective mechanisms of ketone bodies in migraine prevention". Nutrients. 11, 811, 2019.
Goschorska, G. Izabela, B. Irena, and Barczak, "The Use of Antioxidants in the Treatment of Migraine" Antioxidants 9(2):116, 2020.
D.L. Kasper, A.S. Fauci, S.L. Hauser, D. L.ongo, J.L. Jameson, and J. Loscalzo, "migraine and other primary headache disorders". Harrison's Principles of Internal Medicine 20/E (Vol1 & Vol2). New York, NY: McGraw-Hill Education. Chapter 422, 2018.
S. Sacco, M. Braschinsky, A. Ducros, C. Lampl, P. Little, and A.M. Brink, "European headache federation consensus on the definition of resistant and refractory migraine". J Headache Pain. 21:76, 2020
A. Straube, A. and Andreou, "Primary headaches during lifespan". J Headache Pain. 20:35, 2019.
A.P. Andreou, "Edvinsson L. Mechanisms of migraine as a chronic evolutive condition". J Headache Pain. 20:117, 2019.
M. Leonardi, A. and Raggi, "A narrative review on the burden of migraine: when the burden is the impact on people's life". J Headache Pain. 20:41, 2019.
S. Safiri, H. Pourfathi, A. Eagan, M. A. Mansournia, M. T. Khodayari, and M. J. M. Sullman, "Global, regional, and national burden of migraine in 204 countries and territories", 1990 to 2019. PAIN. 163:e293–309, 2022.
M. Bonafede, S. Sapra, N. Shah, S. Tepper, K. Cappell, and P. Desai, " Direct and indirect healthcare resource utilization and costs among migraine patients in the United States". Headache J Head Face Pain. 58:700–14, 2018.
C. Bernstein, and R. Burstein, "Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology". JCN. 8:89–99, 2012.
A. May, and L.H. Schulte, "Chronic migraine: risk factors, mechanisms and treatment". Nat Rev Neurol. 12:455–64, 2016.
M. Torres-Ferrús, F. Ursitti, A. Alpuente, F. Brunello, D. Chiappino, and T. de Vries T. "From transformation to chronification of migraine: pathophysiological and clinical aspects". J Headache Pain. 21:42, 2020.
J. Olesen, JR. Burstein, M. Ashina, and P. Tfelt-Hansen, "Origin of pain in migraine: evidence for peripheral sensitization", Lancetneurology,8(7),679–90, 2009.
M. Viana, G. Sances, M. Linde, G. Nappi, F. Khaliq, P. J. Goadsby, and C. Tassorelli "Prolonged migraine aura: new insights from a prospective diary‐aided study". J Headache Pain. 19, 77, 2018.
J. M. Borkum, "Migraine triggers and oxidative stress: a narrative review and synthesis". Headache. 56, 12–35, 2015.
M. Goschorska, I. Baranowska‐Bosiacka, I. Gutowska, E. Metryka, M. Skórka‐ Majewicz, and D. Chlubek, "Potential role of fluoride in etiopathogenesis of the Alzheimer’s Disease". Int J Mol Sci. 19, 3956, 2018.
A. Aboonabi, R.R. Meyer, I. and Singh, "The association between metabolic syndrome components and the development of atherosclerosis". J Hum Hypertens. 33, 844–855, 2019
M. G. Tozzi‐Ciancarelli, G. De Matteis, C. Di Massimo, C. Marini, I. Ciancarelli, and A. Carolei, "Oxidative stress and platelet responsiveness in migraine". Cephalgia.17, 580–584, 1997.
R. Alp, S. Selek, S.I. Alp, A. Taşkin, and A. Koçyiğit, "Oxidative and antioxidative balance in patients with migraine". Eur Rev Med Pharmacol Sci. 14, 877–882, 2010.
S. Geyik, E. Altunisik, A.M. Neyal, and S. Taysi, "Oxidative stress and DNA damage in patients with migraine". J Headache Pain, 17, 10, 2016.
M. Yigit, O. Sogut, O. Tataroglu, A. Yamanoglu, E. Yigit, E.M. Güler, O.F. Ozer, and A. Kocyigit, "Oxidative/antioxidative status, lymphocyte DNA damage, and urotensin‐2 receptor level in patients in migraine attacks". Neuropsychiatr Dis Treat. 14, 367–374, 2018.
H.O. Yazar, T. Yazar, A. Aygun, S. Kaygisiz, and D. Kirbas, " Evaluation of simple inflammatory blood parameters in patients with migraine". Ir J Med Sci. 189:677–83, 2020.
S.E. Erdener, Z. Kaya, and T. Dalkara, "Parenchymal neuroinflammatory signaling and dural neurogenic inflammation in migraine". J Headache Pain. 22:138, 2021.
K.H. Xie, L.L. Liu, C.Y. Su, X.F. Huang, B.X. Wu, and R.N. Liu, "Low antioxidant status of serum uric acid, bilirubin, albumin, and creatinine in patients with benign paroxysmal positional vertigo". Front Neurol. 11:601695, 2020.
O.A.Thecla, O.E. Benjiamine, N.E. Chijioke, and O.N. Charles, " Antioxidants for the Prevention and Treatment of Non-communicable Diseases" Journal of Exploratory Research in Pharmacology 2022;7(3):178-188, 2022.
A. Oterino, N. Valle, Y. Bravo, P. Munoz, and P. Sander-Velasco, "MTHFR T677 homozygosis influences the presence of aura in migraineurs". Cephalalgia. 24(6): 491– 4, 2004.
M.M. Al-Qasmi, K. Athanas, KR.M. Dafer, and G.E. Tejen, "Von Willebrand factor is elevated in migraineurs with aura, transient ischemic attacks, and stroke: a retrospective analysis (abstr.)". Neurology. 54: A405, 2017.
F. Cacciapuoti, "Lowering homocysteine levels may prevent cardiovascular impairments? Possible therapeutic behaviors" Blood Coag. Fibrinol. 23: 677– 9, 2012.
N.E. Elyas, A.S. Mahmood, D. Monireh, G. Faezeh, G. Abed, A. Pishva, and T.E. Ali, " The Role of Nutrients in the Pathogenesis and
Treatment of Migraine Headaches: Review" Biomed Pharmacother. 102: 317–325, 2018.
R.B. Lipton, and S.D. Silberstein, "Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention". Headache. 55,103–122, 2015.
H.C. Diener, "Headache: insight, understanding, treatment and patient management". Int J Clin Pract Suppl. 178, 33–36, 2013.
T. Rajapakse, and W.J. Davenport, "Phytomedicines in the treatment of migraine". CNS Drugs. 33, 399–415, 2019.
S.L. Orr, "The evidence for the role of nutraceuticals in the menagement of pediatric migraine:" a review. Curr Pain Headache Rep. 22, 37, 2018.
F. D’Onofrio, S. Raimo, D. Spitaleri, G. Casucci, and G. Bussone, "Usefulness of nutraceuticals in migraine prophylaxis". Neurol Sci. 38, S117–S120, 2017.
A. Baiano, and M.A. del Nobile, "Antioxidant compounds from vegetable matrices: Biosynthesis, occurrence, and extraction systems". Crit. Rev. Food Sci Nutr. 56, 2053–2068, 2015.
P. Ferroni, P. Barbanti, D. Della‐Morte, R. Palmirotta, E. Jirillo, and F. Guadagni, "Redox Mechanisms in Migraine: Novel Therapeutics and Dietary Interventions". Antioxid Redox Signal. 28, 1144–1183, 2018.
P. Chiaiese, G. Corrado, M. Minutolo, A. Barone, and A. Errico, "Transcriptional Regulation of Ascorbic Acid During Fruit Ripening in Pepper (Capsicum annuum) Varieties with Low and High Antioxidants Content". Plants. 8, 206, 2019.
N. Alshkh, A.D. de Camargo, and F. Shahidi, "Phenolics of selected lentil cultivars: Antioxidant activities and inhibition of low-density lipoprotein and DNA damage". J. Funct. Foods.18:1022–1038, 2015.
H. Abdel-Shafy, and M.S.M. Mansour, Polyphenols: Properties, occurrence, Content in food, and potential effects. In: Chandra R., Gurjar B.R., Govil J.N., editors". Environmental Science and Engineering. Studium Press LLC; Houston, TX, USA. pp. 232–261. Volume 6: Toxicology, 2017.
R.K. Single, A.K. Dubey, A. Garg, R.K. Sharma, M. and Fiorino . "Natural polyphenols: Chemical Classification, definition of classes, subcategories, and structure". J. AOAC Int.102:1397–1400, 2019.
S. Dirimanov, and P. Högger, "Screening of inhibitory effects of polyphenols on Akt-phosphorylation in endothelial cells and determination of structure-activity features". Biomolecules. 9:219, 2019.
D.R. Chaliha, M. Vaccarezza, R. Takechi, V. Lam, E. Visser, and P. Drummond, "A Paradoxical Vasodilatory Nutraceutical Intervention for Prevention and Attenuation of Migraine-A Hypothetical Review". Nutrients. 12(8), 2020.
K. Thorlund, C. Sun-Edelstein, E. Druyts, S. Kanters, S. Ebrahim, and R. Bhambri, "Risk of medication overuse headache across classes of treatments for acute migraine". The journal of headache and pain. 17(1):107, 2016.
M. Ashina, D.C. Buse, H. Ashina,P. Pozo-Rosich, M.F. Peres, and M.J. Lee, "Migraine: integrated approaches to clinical management and emerging treatments". The Lancet, 2021.
M. Wlosinska, A.C. Nilsson, J. Hlebowicz, M. Malmsjö, M. Fakhro, and S. Lindstedt, "Aged garlic extract preserves cutaneous microcirculation in patients with increased risk for cardiovascular diseases: a double‐ blinded placebo‐controlled study". International wound journal. 16(6):1487-93, 2019.
S. Dunaway, R. Odin, L. Zhou, L. Ji, Y. Zhang, and A.L. Kadekaro, "Natural antioxidants: Multiple mechanisms to protect skin from solar radiation". Front. Pharmacol. 9, 392, 2018.
S.N. Muhammad, k. Imran, U. Inam, M. Khushi, and A. Firoz, " Allicin, an Antioxidant and Neuroprotective Agent, Ameliorates Cognitive Impairment" Antioxidants, 11(1), 87, 2022.
S.R. Pinnell, "Cutaneous photodamage, oxidative stress, and topical antioxidant protection". J. Am. Acad. Dermatol. 48, 1–22, 2003.
C. Oresajo, S. Pillai, M. Manco, M. Yatskayer, and D. McDaniel, "Antioxidants and the skin: Understanding formulation and efficacy". Dermatol. Ther. 25, 252–259, 2012.
H.R. Rahimi, R. Nedaeinia, A. Sepehri Shamloo, S. Nikdoust, and O.R. Kazemi "Novel delivery system for natural products": Nano-curcumin formulations. Avicenna J. Phytomed. 6, 383–398, 2016.
A.E. Bulboacă, A.S. Porfire, L.R. Tefas, P.M. Boarescu, S.D. Bolboacă, I.C. Stănescu, A.C. Bulboacă, and G. Dogaru, "Liposomal curcumin is better than curcumin to alleviate complications in experimental diabetic mellitus". Molecules. 24, 846, 2019.
K. Maiti, K. Mukherjee, A. Gantait, B.P. Saha, and P.K. Mukherjee, "Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats". Int. J. Pharm. 330, 155–163, 2007.
A. Shakeri, Y. Panahi, T.P. Johnston, and A. Sahebkar, "Biological properties of metal complexes of curcumin". BioFactors. 45, 304–317, 2019.
R. Tabanelli, S. Brogi, and V. Calderone, "Improving curcumin bioavailability: Current strategies and future perspectives". Pharmaceutics. 13, 1715, 2021.
M.M. Yallapu, M. Jaggi, and S.C. Chauhan, "β-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells". Colloids Surf. B Biointerfaces. 79, 113–125, 2010.
A.E. Bulboacă, S.D. Bolboacă, I.C. Stănescu, C.A. Sfrângeu, A. Porfire, L. Tefas, and A.C. Bulboacă, "The effect of intravenous administration of liposomal curcumin in addition to sumatriptan treatment in an experimental migraine model in rats". Int J Nanomedicine. 13, 3093–3103, 2018.
A.E. Bulboacă, S.D. Bolboacă, I.C. Stănescu, C.A. Sfrângeu, and A.C. Bulboacă, "Preemptive Analgesic and Antioxidative Effect of Curcumin for Experimental Migraine". Biomed Res Int. 2017, 2017.
M. Abdolahi, A. Tafakhori, M. Togha, A.A. Okhovat, F. Siassi, M.R. Eshraghian, M. Sedighiyan, M. Djalali, N. Mohammadzadeh Honarvar, and M. Djalali, "The synergistic effects of ω‐3 fatty acids and nano‐ curcumin supplementation on tumor necrosis factor (TNF)‐α gene expression and serum level in migraine patients". Immunogenetics. 69, 371–378, 2017.
M. Parohan, P. Sarraf, M.H. Javanbakht, A.R. Foroushani, S. Ranji‐Burachaloo, and M. Djalali, "The synergistic effects of nano‐curcumin and coenzyme Q10 supplementation in migraine prophylaxis: a randomized, placebo‐controlled, double‐blind trial". Nutr Neurosci. 26, 1–10, 2019.
H.T. Liu, S.B. Cheng, Y.C. Huang, Y.T. Huang, and P.T. Lin, "Coenzyme Q10 and Oxidative Stress: Inflammation Status in Hepatocellular Carcinoma Patients after Surgery". Nutrients, 9, 29, 2017.
T. Priti, t. Pooja, I. Fahadul, T. Sandeep, S. Muddaser, D.H. Zareen, H.R. Md, N. Ajneiszka, S.A. Ibtesam, O.G. Mousa, R.H.M. Hanan, M.A. Mardi, Z.N. Mohammed, K. Natalia, and M.A. Mohamed, " The Multifaceted Role of Curcumin in Advanced Nanocurcumin Form in the Treatment and Management of Chronic Disorders" Molecules, 26(23), 7109, 2021.
D. Mantle, and I. Hargreaves, "Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview". Antioxidants, 8, 44, 2019.
T. Rajapakse, and T. Pringsheim, "Nutraceuticals in migraine: a summary of existing guidelines for use." Headache, 56, 808–816, 2016.
C.H. Gaul, H.C.H. Diener, and U. Danesch, "Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo‐controlled, double‐blind, multicenter trial". J Headache Pain, 16, 32, 2015.
T.J. Schwedt, "Preventive Therapy of Migraine. Continuum (Minneap Minn)". Headache, 24,1052–1065, 2018.
M. Dahri, A. Tarighat‐Esfajani, M. Asghari‐Jafarabadi, and M. Hashemilar, "Oral coenzyme Q10 supplementation in patients with migraine effects on clinical features and inflammation markers". Nutr Neurosci, 22, 607–615,2019.
M.S. Kim, J.H. Bang, J. Lee, J.S. Han, T.G. Baik, and W.K. Jeon, "Ginkgo biloba L. extract protects against chronic cerebral hypoperfusion by modulating neuroinflammation and the cholinergic system". Phytomedicine, 23, 1356–1364, 2016.
J. Tulsulkar, and Z.A. Shah, "Ginkgo biloba prevents transient global ischemia‐induced delayed hippocampal neuronal death through antioxidant and anti‐inflammatory mechanism". Neurochem Int, 62, 189–197, 2013.
M.S. Choi, J.K. Kim, D.H. Kim, and H.H. Yoo, "Effects of gut microbiota on the bioavailability of bioactive compounds from ginkgo leaf extracts". Metabolites, 9, 132, 2019.
C. Shi, L. Zhao, B. Zhu, Q. Li, D.T. Yew, Z. Yao, and J. Xu, " Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against β‐amyloid peptide‐induced toxicity in SH‐SY5Y cells". Chem Biol Interact, 115–123, 2009.
G. D’Andrea, S. Cevoli, and D. Cologno, "Herbal therapy in migraine". Neurol Sci, 35 (Suppl 1), S135–S140, 2014.
Z.A. Shah, S.E. Nada, and S. Dore, "Heme oxygenase 1, beneficial role in permnent ischemic stroke and in Ginkgo Biloba (EGB761) neuroprotection". Neuroscience, 180:248–255, 2011.
G. D’Andrea, G. Bussone. G. Allais, M. Aggugia, F. D’Onofrio, M. Maggio, F. Moschiano, M.G. Saracco, M.G. Terzi, V. Petretta, and C. Benedetto, "Efficiacy of ginkgolide B in the prophylaxis of migraine with aura". Neurol Sci, 30 (suppl 1), S121–S124, 2009.
R. Li, B. Chen, W. Wu, L. Bao, J. Li, and R. Qi, "Ginkgolide B suppresses intercellular adhesion molecule‐1 expression via blocking nuclear factor‐kB activation in human vascular endothelial cells stimulated by oxidized low‐density lipoprotein". J Pharmacol Sci, 110, 362–369, 2009.
A. Pareek, M. Suthar, G.S. Rathore, and V. Bansal, "Feverfew (Tanacetum Parthenium L): a systematic review". Pharmacogn Rev, 5, 103–110, 2011.
S.H. Hwang, H.Y. Kim, Y.N.G. Quispe, Z. Wang, G. Zuo, and S.S. Lim, S.S. "Aldose Reductase, Protein Glycation Inhibitory and Antioxidant of Peruvian Medicinal Plants: The Case of Tanacetum parthenium L. and Its Constituents." Molecules, 24, 2019.
C. Wu, CF. Chen, X. Wang, H.J. Kim, G.Q. He, V. Haley‐Zitlin, and G. Huang, "Antioxidant constituents in feverfew (Tanacetu Parthenium) extract and their chromatographic quantification". Food Chem, 96, 220– 227,2006.
G.D. Volta, P. Zavarise, L. Perego, L. Savi, and A. Pezzini " Comparison of the Effect of Tanacethum Parthenium, 5‐Hydroxy Tryptophan, and Magnesium (Aurastop) versus Magnesium Alone on Aura Phenomenon and Its Evolution". Pain Res Manag, 2019.doi: 10.1155/2019/6320163, 2019.
Downloads
Published
License
Copyright (c) 2023 University of Thi-Qar Journal of Science
This work is licensed under a Creative Commons Attribution 4.0 International License.
